Qlife Holding AB (publ) (QLIFE.ST)
- Previous Close
0.0033 - Open
0.0034 - Bid 0.0031 x --
- Ask 0.0032 x --
- Day's Range
0.0027 - 0.0035 - 52 Week Range
0.0027 - 0.5000 - Volume
155,074,730 - Avg. Volume
45,335,727 - Market Cap (intraday)
11.714M - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
0.00 - EPS (TTM)
1.3000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.07
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
www.qlifeholding.comRelated News
Performance Overview: QLIFE.ST
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QLIFE.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QLIFE.ST
Valuation Measures
Market Cap
12.08M
Enterprise Value
17.67M
Trailing P/E
0.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.60
Price/Book (mrq)
0.13
Enterprise Value/Revenue
13.49
Enterprise Value/EBITDA
-0.29
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-84.51%
Return on Equity (ttm)
-470.28%
Revenue (ttm)
244k
Net Income Avi to Common (ttm)
-159.96M
Diluted EPS (ttm)
1.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.66M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
9.39M
Research Analysis: QLIFE.ST
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: QLIFE.ST
QLIFE.ST does not have Company Insights